Literature DB >> 2538186

Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages.

G R Elliott1, A P Lauwen, I L Bonta.   

Abstract

1. The calcium ionophore, A23187, stimulated leukotriene B4 (LTB4), thromboxane B2 (TxB2) and prostaglandin E2 (PGE2) synthesis by 4 day carrageenin-elicited rat peritoneal macrophages. 2. At concentrations of 2 x 10(-7)-2 x 10(-5) M indomethacin and aspirin enhanced A23187-stimulated LTB4 synthesis and inhibited PGE2 and TXB2 formation. 3. PGE2 inhibited A23187-stimulated LTB4 and TXB2 formation as well as the augmentation of LTB4 release caused by aspirin and indomethacin. However, PGE2 was ineffective when the cells were challenged with arachidonic acid (AA). 4. Dibutyryl adenosine 3':5'-cyclic monophosphate (db-cyclic AMP) partially inhibited A23187-stimulated LTB4 production. 5. Our results suggest that PGE2 inhibits macrophage LTB4 synthesis by limiting the availability of AA. Indomethacin and aspirin, possibly by removing the regulatory effect of PGE2, promote the synthesis of the pro-inflammatory LTB4.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538186      PMCID: PMC1854358          DOI: 10.1111/j.1476-5381.1989.tb11812.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Indomethacin increases the formation of lipoxygenase products in calcium ionophore stimulated human neutrophils.

Authors:  J C Docherty; T W Wilson
Journal:  Biochem Biophys Res Commun       Date:  1987-10-29       Impact factor: 3.575

2.  Cyclooxygenase inhibitors promote the leukotriene C4 induced release of beta-glucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses.

Authors:  E J Schenkelaars; I L Bonta
Journal:  Int J Immunopharmacol       Date:  1986

3.  The role of macrophages in inflammation.

Authors:  D Gemsa; H G Leser; M Seitz; M Debatin; E Bärlin; W Deimann; W Kramer
Journal:  Agents Actions Suppl       Date:  1982

Review 4.  Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Minireview with emphasis on macrophage-mediated effects.

Authors:  I L Bonta; M J Parnham
Journal:  Int J Immunopharmacol       Date:  1982

5.  Assessment of leukotriene B4 synthesis in human lymphocytes by using high performance liquid chromatography and radioimmunoassay methods.

Authors:  P E Poubelle; P Borgeat; M Rola-Pleszczynski
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

6.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

7.  Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.

Authors:  E A Ham; D D Soderman; M E Zanetti; H W Dougherty; E McCauley; F A Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Reactive oxygen production, arachidonate metabolism and cyclic AMP in macrophages.

Authors:  L K Lim; N H Hunt; M J Weidemann
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

9.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  The phosphatidylinositol cycle and the regulation of arachidonic acid production.

Authors:  E G Lapetina; M M Billah; P Cuatrecasas
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

View more
  11 in total

1.  Leukotriene B4 stimulation of macrophage cyclooxygenase metabolite synthesis.

Authors:  G R Elliott; A P Lauwen; I L Bonta
Journal:  Agents Actions       Date:  1991-01

2.  Dibutyryl cytidine 3':5'-cyclic monophosphate; an inhibitor of A23187-stimulated macrophage leukotriene B4 synthesis.

Authors:  G R Elliott; A P Lauwen; I L Bonta
Journal:  Agents Actions       Date:  1991-01

Review 3.  Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.

Authors:  Megan N Ballinger; Tracy R McMillan; Bethany B Moore
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

4.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

Authors:  A S Cowburn; K Sladek; J Soja; L Adamek; E Nizankowska; A Szczeklik; B K Lam; J F Penrose; F K Austen; S T Holgate; A P Sampson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.

Authors:  E Kankuri; K Vaali; R Korpela; I Paakkari; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

6.  Influence of no-donor (SIN-1) on functions of inflammatory cells.

Authors:  A Dembińska-Kieć; A Zmuda; J Marcinkiewicz; H Sinzinger; R J Gryglewski
Journal:  Agents Actions       Date:  1991-01

7.  Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors.

Authors:  A Shahbazian; R Schuligoi; A Heinemann; B A Peskar; P Holzer
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

8.  The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.

Authors:  A M Sebastião; T W Stone; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

9.  Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation.

Authors:  J Raud
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

10.  Pharmacological modulation of rat monocytes: in vivo effects on Ia expression and interleukin-1 production.

Authors:  E J Schenkelaars; H N Singh; R L Goldberg; J R Doughty; J Peppard; G DiPasquale; F Quagliata
Journal:  Agents Actions       Date:  1991-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.